Tropism of human adenovirus type 5-based vectors in swine and their ability to protect against transmissible gastroenteritis coronavirus

Journal of Virology

Volumn 70, Issue 6, 1996, Pages 3770-3780

  Torres, Juan M ^a   Alonso, Covadonga ^b   Ortega, Ana ^b   Mittal, Suresh ^c,d   Graham, Frank ^c   Enjuanes, Luis ^a  

^a CENTRO NACIONAL DE BIOTECNOLOGÍA   (Spain)

^b Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria   (Spain)

^c MCMASTER UNIVERSITY   (Canada)

^d PURDUE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ARTICLE; CORONAVIRUS; HUMAN; HUMAN ADENOVIRUS; HUMAN CELL; INFECTION SENSITIVITY; NONHUMAN; PRIORITY JOURNAL; SWINE; VIRUS REPLICATION; VIRUS TRANSMISSION;

EID: 0029992355     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.6.3770-3780.1996     Document Type: Article

References (60)

1. Alonso, C. Unpublished results.
2. 1a.Anderson, M., S. Paabo, T. Nilsson, and P. A. Peterson. 1985. Impaired intracellular transport of class I MHC antigens as a possible means for adenovirus to evade immune surveillance. Cell 43:215-222.
3. Berkner, K. L. 1988. Development of adenovirus vectors for the expression of heterologous genes. BioTechniques 6:616-629.
4. Berschneider, H. M., and D. W. Powell. 1992. Fibroblasts modulate intestinal secretory response to inflammatory mediators. J. Clin. Invest. 89:484-489.
5. Bett, A. J., V. Krougliak, and F. L. Graham. 1995 DNA sequence of the deletion/insertion in early region 3 of Ad5 d1309. Virus Res. 39:75-82.
6. Bett, A. J., L. Prevec, and F. L. Graham. 1993. Packaging capacity and stability of human adenovirus type 5 vectors. J. Virol. 67:5911-5921.
7. Betts, A. O., A. R. Jennings, P. H. Lament, and Z. Page. 1962. Inoculation of pigs with adenovirus of man. Nature (London) 193:45-46.
8. Blair, G. E., S. C. Dixon, S. A. Griffiths, and M. E. Zajdel. 1989. Restricted replication of human adenovirus type 5 in mouse cell lines. Virus Res. 14:339-346.
9. Bohl, E. H., R. K. P. Gupta, M. V. F. Olquin, and L. J. Saif. 1972. Antibody response in serum, colostrum, and milk of swine after infection or vaccination with transmissible gastroenteritis virus. Infect. Immun. 6:289-301.
10. Branton, P. E., M. Evelegh, D. T. Rowe, F. L. Graham, and S. Bacchetti. 1985. Studies on the biological activity of the 72,000 dalton single stranded binding protein from early region 2A of human adenovirus 5 using monoclonal antibodies. Can. J. Biochem. Cell Biol. 63:941-952.
11. Brasier, A. R., J. E. Tate, and J. F. Habener. 1989. Optimized use of the firefly luciferase assay as reporter gene in mammalian cells line. BioTechniques 7:1116-1122.
12. Buchmeier, M. J., H. A. Lewicki, P. J. Talbot, and R. L. Knobler. 1984. Murine hepatitis virus-4 (strain JHM)-induced neurologic disease is modulated in vivo by monoclonal antibody. Virology 132:261-270.
13. Burgert, H. G., and S. Kvist. 1985. An adenovirus type 2 glycoprotein blocks cell surface expression of human histocompatibility class I antigens. Cell 41:987-997.
14. Correa, I., G. Jiménez, C. Suñé, M. J. Bullido, and L. Enjuanes. 1988. Antigenic structure of the E2 glycoprotein from transmissible gastroenteritis coronavirus. Virus Res. 10:77-94.
15. De Diego, M., M. D. Laviada, L. Enjuanes, and J. M. Escribano. 1992. Epitope specificity of protective lactogenic immunity against swine transmissible gastroenteritis virus. J. Virol. 66:6502-6508.
16. De Diego, M., F. Rodriguez, C. Alcaraz, N. Gómez, C. Alonso, and J. M. Escribano. 1994. Characterization of the IgA and subclass IgG responses to neutralizing epitopes after infection of pregnant sows with the transmissible gastroenteritis virus or the antigenically related porcine respiratory coronavirus. J. Gen. Virol. 75:2585-2593.
17. Delmas, B., J. Gelfi, and H. Laude. 1986. Antigenic structure of transmissible gastroenteritis virus. II. Domains in the peplomer glycoprotein. J. Gen. Virol. 67:1405-1418.
18. Delmas, B., D. Rasschaert, M. Godet, J. Gelfi, and H. Laude. 1990. Four major antigenic sites of the coronavirus transmissible gastroenteritis virus are located on the amino-terminal half of spike protein. J. Gen. Virol. 71:1313-1323.
19. Enjuanes, L., and B. A. M. Van der Zeijst. 1995. Molecular basis of transmissible gastroenteritis coronavirus (TGEV) epidemiology, p. 337-376. In S. G. Siddell (ed.), Coronaviruses. Plenum Press, New York.
20. Gebauer, F., W. A. P. Posthumus, I. Correa, C. Suñé, C. M. Sánchez, C. Smerdou, J. A. Lenstra, R. Meloen, and L. Enjuanes. 1991. Residues involved in the formation of the antigenic sites of the S protein of transmissible gastroenteritis coronavirus. Virology 183:225-238.
21. Ginsberg, H. S. 1984. The adenovirus. Plenum Press, New York.
22. Ginsberg, H. S., R. L. Horswood, R. M. Chanock, and G. A. Prince. 1952. Quantitative aspects of the multiplication of influenza A virus in the mouse lung. Relation between the degree of viral multiplication and the extent of pneumonia. J. Exp. Med. 95:135-145.
23. Ginsberg, H. S., U. Lundholm-Beauchamp, R. L. Horswood, B. Pernis, W. S. M. Wold, R. M. Chanock, and G. M. Prince. 1989. Role of early region 3 (E3) in pathogetiesis of adenovirus disease. Proc. Natl. Acad. Sci. USA 86:3823-3827.
24. Godet, M., J. Grosclaude, B. Delmas, and H. Laude. 1994. Major receptor-binding and neutralization determinants are located within the same domain of the transmissible gastroenteritis virus (coronavirus) spike protein. J. Virol. 68:8008-8016.
25. Gooding, L. R., and W. S. M. Wold. 1990. Molecular mechanisms by which adenoviruses counteract antiviral immune defenses. Crit. Rev. Immunol. 10:53-71.
26. Graham, F. L., and L. Prevec. 1992. Adenovirus-based expression vectors and recombinant vaccines, p. 363-385. In R. W. Ellis (ed.), Vaccines: new approaches to immunological problems. Butterworth-Heinemann, Stoneham, Mass.
27. Graham, F. L., J. Smiley, W. C. Russell, and R. Nairn. 1977. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J. Gen. Virol. 36:59-72.
28. Grand, R. J. A. 1987. The structure and functions of the adenovirus early region 1 proteins. Biochem. J. 241:267-279.
29. Hitt, M., A. J. Belt, C. Addison, L. Prevec, and L. Graham. 1995. Techniques for human adenovirus vector construction and characterization, p. 13-30. In K. W. Adolph (ed.), Methods in molecular genetics. Academic Press, Orlando, Fla.
30. Hitt, M., A. J. Bett, L. Prevec, and F. L. Graham. 1994. Construction and propagation of human adenovirus vectors, p. 479-490. In J. E. Celis (ed.), Cell biology: a laboratory handbook. Academic Press, Orlando, Fla.
31. Hjorth, R. N., G. M. Bonde, and W. A. Pierachala. 1988. A new hamster model for adenovirus vaccination. Arch. Virol. 100:279-283.
32. Horsfall, F. L., J. Ginsberg, and H. S. Ginsberg. 1951. The dependence of the pathological lesion upon the multiplication of pneumonia virus of mice (PVM). Kinetic relation between the degree of viral multiplication and the extent of pneumonia. J. Exp. Med. 93:139-150.
33. Jackson, S., J. Song, and T. J. Kindt. 1982. Microdetermination of rabbit immunoglobulin allotypes by elisa using specific antibodies conjugated with peroxidase or with biotin. J. Immunol. Methods 48:299-309.
34. Jiménez, G., I. Correa, M. P. Melgosa, M. J. Bullido, and L. Enjuanes. 1986. Critical epitopes in transmissible gastroenteritis virus neutralization. J. Virol. 60:131-139.
35. Jones, N., and T. Shenk. 1979. Isolation of adenovirus type 5 host range deletion mutants defective for transformation of rat embryo cells. Cell 17: 683-689.
36. Jutterman, R., U. Weyer, and W. Doerfler. 1989. Defect of adenovirus type 12 replication in hamster cells: absence of transcription of viral virus-associated and L1 RNAs. J. Virol. 63:3535-3540.
37. Klessig, D. F. 1984. Adenovirus-simian virus 40 interactions, p. 399-449. In H.S. Ginsberg (ed.), The adenovirus. Plenum Press, New York.
38. Laude, H., J. Gelfi, L. Lavenant, and B. Charley. 1992. Single amino acid changes in the viral glycoprotein M affect induction of alpha interferon by the coronavirus transmissible gastroenteritis virus. J. Virol. 66:743-749.
39. Liu, Y.-J., D. E. Joshua, G. T. Williams, C. A. Smith, J. Gordon, and I. C. M. MacLennan. 1989. Mechanism of antigen-driven selection in germinal centres. Nature (London) 342:929-931.
40. Lubeck, M. D., R. J. Natuk, M. Chengalvala, P. K. Chanda, K. K. Murthy, S. Murthy, S. Mizutani, S. G. Lee, M. S. Wade, B. M. Bhat, R. Bhat, S. K. Dheer, J. W. Eichberg, A. R. Davis, and P. P. Hung. 1994. Immunogenicity of recombinant adenovirus-human immunodeficiency virus vaccines in chimpanzees following intranasal administration. AIDS Res. Hum. Retroviruses 10:1443-1449.
41. Lunney, J. K., M. D. Pescovitz, and D. H. Sachs. 1986. The swine major histocompatibility complex: its structure and function, p. 1821-1836. In M. E. Tumbleason (ed.), Swine in biomedical research. Plenum Press, New York.
42. Meiklejohn, G. 1983. Viral respiratory disease at Lowry Air Force Base in Denver, 1952-1982. J. Infect. Dis. 148:775-784.
43. Mittal, S. K., M. R. McDermott, D. C. Johnson, L. Prevec, and F. L. Graham. 1993. Monitoring foreign gene expression by a human adenovirus based vector using the firefly luciferase as a reporter gene. Virus. Res. 28:67-90.
44. Natuk, R. J., M. D. Lubeck, P. K. Chanda, M. Chengalvala, M. S. Wade, S. C. S. Murthy, J. Wilhelm, S. K. Vernon, S. K. Dheer, S. Mizutani, S. G. Lee, K. K. Murthy, J. W. Eichberg, A. K. Davis, and P. P. Hung. 1993. Immunogenicity of recombinant human adenovirus-human immunodeficiency virus vaccines in chimpanzees. AIDS Res. Hum. Retroviruses 9:395-404.
45. Nevins, J. R. 1987. Regulation of early adenovirus gene expression. Microbiol. Rev. 51:419-430.
46. Prevec, L., M. Schneider, K. L. Rosenthal, L. W. Belbeck, J. B. Derbyshire, and F. L. Graham. 1989. Use of human adenovirus-based vectors for antigen expression in animals. J. Gen. Virol. 70:429-434.
47. Prince, G. A., D. D. Porter, A. B. Jenson, R. L. Horswood, R. M. Chanock, and H. S. Ginsberg. 1993. Pathogenesis of adenovirus type-5 pneumonia in cotton rats (Sigmodon hispidus). J. Virol. 67:101-111.
48. Saif, L. J., E. H. Bohl, and R. K. P. Gupta. 1972. Isolation of porcine immunoglobulins and determination of the immunoglobulin class of transmissible gastroenteritis viral antibodies. Infect. Immun. 6:600-609.
49. Saif, L. J., and R. D. Wesley. 1992. Transmissible gastroenteritis, p. 362-386. In A. D. Leman, B. Straw, W. L. Mengeling, S. D' Allaire, and D. J. Taylor (ed.), Diseases of swine. Iowa State University Press, Ames, Iowa.
50. Sánchez, C. M., G. Jiménez, M. D. Laviada, I. Correa. C. Suñé, M. J. Bullido, F. Gebauer, C. Smerdou, P. Callebaut, J. M. Escribano, and L. Enjuanes. 1990. Antigenic homology among coronaviruses related to transmissible gastroenteritis virus. Virology 174:410-417.
51. Scicchitano, R., A. Stanistz, P. B. Ernst, and J. Bienenstock. 1988. A common mucosal immune system revisited, p. 1-34. In A. J. Husband (ed.), Migration and homing of lymphoid cells. CRC Press Inc., Boca Raton, Fla.
52. Silverstein, G., and W. A. Strohl. 1986. Restricted replication of adenovirus type 2 in mouse Balb/3T3 cells. Arch. Virol. 87:241-264.
53. Spaan, W., D. Cavanagh, and M. C. Horzinek. 1990. Immunochemistry of viruses. II. The basis for serodiagnosis and vaccines, p. 359-379. In M. H. V. van Regenmortel and A. R. Neurath (ed.), Coronaviruses. Elsevier. Amsterdam.
54. Suñé, C., G. Jiménez, I. Correa, M. J. Bullido, F. Gebauer, C. Smerdou, and L. Enjuanes. 1990. Mechanisms of transmissible gastroenteritis coronavirus neutralization. Virology 177:559-569.
55. Takafuji, E., J. C. Gaydos, R. G. Allen, and F. H. Top. 1979. Simultaneous administration of live, enteric-coated adenovirus types 4, 7, and 21 vaccines: safety and immunogenicity. J. Infect. Dis. 140:48-53.
56. Tew, J. G., M. H. Kosco, G. F. Burton, and A. K. Szakal. 1990. Follicular dendritic cells as accessory cells. Immunol. Rev. 117:185-211.
57. Torres, J. M., C. Sanchez, C. Suñé, C. Smerdou, L. Prevec, F. L. Graham, and L. Enjuanes. 1995. Induction of antibodies protecting against transmissible gastroenteritis coronavirus (TGEV) by recombinant adenovirus expressing TGEV spike protein. Virology 213:503-516.
58. VanCott, J. L., T. A. Brim, J. K. Lunney, and L. J. Saif. 1994. Contribution of antibody-secreting cells induced in mucosal lymphoid tissues of pigs inoculated with respiratory or enteric strains of coronavirus to immunity against enteric coronavirus challenge. J. Immunol. 152:3980-3990.
59. VanCott, J. L., T. A. Brim, R. A. Simkins, and L. J. Saif. 1993. Isotype-specific antibody-secreting cells to transmissible gastroenteritis virus and porcine respiratory coronavirus in gut- and bronchus-associated lymphoid tissues of suckling pigs. J. Immunol. 150:3990-4000.
60. Wold, W. S. M., and L. R. Gooding. 1991. Region E3 of adenovirus: a cassette of genes involved in host immunosurveillance and virus-cell interactions. Virology 184:1-8.